CASE SERIES OF LASSA FEVER PATIENTS WITH ADVERSE OUTCOMES DESPITE HIGHER CT VALUES

Main Article Content

Isaac Ihinmikaye
Temitope Emmanuel -Taiwo
Olufemi Oladele Ayodeji
Adetumi Adetunji Subulade

Abstract









Lassa fever is endemic to West Africa. It is associated with an acute hemorrhagic illness. It is diagnosed through reverse transcription polymerase chain reaction (RT-PCR), in which low cycle threshold (Ct) values correspond to high viral load. This paper describes a case series of two patients in Owo, Ondo State, Nigeria (Infection Control and Research Centre, Federal Medical Centre), a National Reference Centre for viral hemorrhagic fever. These cases were confirmed by RC-67 and RC-69 Lazzaro, RC-67, and RC-69 Lazzaro, and RC-67 and RC-69 Lazzaro. We collated clinical and laboratory data as well as the sociodemographic data of the two patients. Both patients were treated in accordance with the guidelines, which include the use of intravenous ribavirin, supportive therapy, and transmission. The first case was a 45-year-old male with CT values of 32.817 (G) and 31.374 (L) who suffered acute kidney injury, haemorrhage, and died 8 days after admission. In the second scenario, a 37-year-old male patient presented with acute kidney injury and viral encephalitis, and was unable to survive 4 days post a session of hemodialysis. His Ct values of 35.88 and 36.25 could suggest the possibility of a poor clinical outcome, albeit the higher Ct value. This shows that viral load is not a complete determinant of the illness's severity. Other factors, such as host attributes, viral heterogeneity, immune dysregulation, possibly late treatment, and others, could significantly influence the illness's course and outcome.






 



Downloads

Download data is not yet available.

Article Details

Section

Original Research Article

How to Cite

Ihinmikaye, I., -Taiwo, T. E., Ayodeji, O. O., & Subulade, A. A. (2026). CASE SERIES OF LASSA FEVER PATIENTS WITH ADVERSE OUTCOMES DESPITE HIGHER CT VALUES. Frontline Professionals Journal, 2(10), 169-176. https://fpjournal.com.ng/index.php/home/article/view/85

References

Akafa, T. A., John, A. I., Oladele, G. O., & Umaru, I. J. (2025). Persistent Threat of Lassa Fever in Nigeria: Epidemiology, Challenges, and Strategies for Effective Management. African Journal of Medicine, Surgery and Public Health Research, 2(2), 270–281. https://doi.org/10.58578/ajmsphr.v2i2.5517

Asogun, A. D., Ochei, O., Moody, V., Abejegah, C., & Okoh, E. (2016). Clinical Presentation and Outcome of Ribavirin-Treated RT-PCR-Confirmed Lassa Fever Patients in ISTH Irrua: A Pilot Study. Research in Health Science, 1(2), 68. https://doi.org/10.22158/rhs.v1n2p68

Besson, M. E., Pépin, M., & Metral, P.-A. (2024). Lassa Fever: Critical Review and Prospects for Control. Tropical Medicine and Infectious Disease, 9(8), 178. https://doi.org/10.3390/tropicalmed9080178

Bhatt, P., Jayaram, A., Varma, M., & Mukhopadhyay, C. (2024). Kinetics of dengue viremia and its association with disease severity: an ambispective study. Virus Disease, 35(2), 250–259. https://doi.org/10.1007/s13337-024-00872-z

Chime, P. E., Chime, E. N., Ndibuagu, E., Ekochin, F. C., Arinze-Onyia, S., & Oti, B. (2020). Lassa Fever Case Report: Challenges in Making Early Diagnosis. Advances in Infectious Diseases, 10(05), 228–234. https://doi.org/10.4236/aid.2020.105020

Choi, M. J., Worku, S., Knust, B., Vang, A., Lynfield, R., Mount, M. R., Objio, T., Brown, S., Griffith, J., Hulbert, D., Lippold, S., Ervin, E., Ströher, U., Holzbauer, S., Slattery, W., Washburn, F., Harper, J., Koeck, M., Uher, C., … DeVries, A. (2018). A Case of Lassa Fever Diagnosed at a Community Hospital—Minnesota 2014. Open Forum Infectious Diseases, 5(7). https://doi.org/10.1093/ofid/ofy131

Dongo, A. E., Kesieme, E. B., Iyamu, C. E., Okokhere, P. O., Akhuemokhan, O. C., & Akpede, G. O. (2013). Lassa fever presenting as acute abdomen: a case series. Virology Journal, 10(1). https://doi.org/10.1186/1743-422x-10-123

Kazachinskaia, E. I., Aripov, V. S., Ivanova, A. V., & Shestopalov, A. M. (2022). Lassa fever. Part 1. Etiology, epidemiology and clinical manifestations. Russian Journal of Infection and Immunity, 12(3), 427–438. https://doi.org/10.15789/2220-7619-eea-1814

Malik, S., Deep, A., Dhasmana, A., Nag, S., Hazra, R., Mondal, S., Agrawal, S., Bora, J., Rustagi, S., Rabaan, A. A., Bouafia, N. A., Alshehri, A. A., Alqahtani, A. S., Yousuf, A. M., Mohanty, A., Padhi, B. K., Rodriguez-Morales, A. J., Barboza, J. J., & Sah, R. (2023). Re-Emerging Lassa Fever Outbreaks: Epidemiological Analysis, Preparedness, and Prevention. In Preprints, 2023.

NewsCAP: Lassa fever found in England. (2022). AJN, American Journal of Nursing, 122(5), 13–13. https://doi.org/10.1097/01.naj.0000830696.33213.17

Ogbaini-Emovon E, Akpede G, Okogbenin S, Osagiede E, Tobin E, Asogun D, (2024). Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria. Open Forum Infect Dis. 11(10):575.

Okogbenin, S., Erameh, C., Okoeguale, J., Edeawe, O., Ekuaze, E., Iraoyah, K., Agho, J., Groger, M., Kreuels, B., Oestereich, L., Babatunde, F. O., Akhideno, P., Günther, S., Ramharter, M., & Omansen, T. (2022). Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections. Emerging Infectious Diseases, 28(10), 2060–2063. https://doi.org/10.3201/eid2810.220625

Olasoju, T. I., Olasoju, M., Dagash, B., Abaye, B., Enumah, C., Isah, S., Bolori, M. T., & Adebowale, O. (2024). Lassa fever in internally-displaced persons’ camp: a case report at zabarmari, borno state, nigeria. In Annals of Ibadan Postgraduate Medicine.

Phipps, J., Passage, B., Sel, K., Martinez, J., Saadat, M., Koker, T., Damaso, N., Davis, S., Palmer, J., Claypool, K., Kiley, C., Pettigrew, R. I., & Jafari, R. (2024). Early adverse physiological event detection using commercial wearables: challenges and opportunities. Npj Digital Medicine, 7(1). https://doi.org/10.1038/s41746-024-01129-1

Russier, M., Pannetier, D., & Baize, S. (2012). Immune Responses and Lassa Virus Infection. Viruses, 4(11), 2766–2785. https://doi.org/10.3390/v4112766

Saka, S. A., Lawal, Q. O., Otaigbe, O., Blackie, F. F., Ighodaro, O., Odafen, P. I., & Okogbenin, S. (2025). Lassa fever survivors: long-term health effects and chronic sequelae – a scoping review. BMC Infectious Diseases, 25(1). https://doi.org/10.1186/s12879-025-11262-1

Siddle, K. J., Eromon, P., Barnes, K. G., Mehta, S., Oguzie, J. U., Odia, I., Schaffner, S. F., Winnicki, S. M., Shah, R. R., Qu, J., Wohl, S., Brehio, P., Iruolagbe, C., Aiyepada, J., Uyigue, E., Akhilomen, P., Okonofua, G., Ye, S., Kayode, T., … Happi, C. T. (2018). Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018. New England Journal of Medicine, 379(18), 1745–1753. https://doi.org/10.1056/nejmoa1804498

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.